Segmentation AI for Pathology Slides Market Report 2026

The segmentation artificial intelligence (AI) for pathology slides market size has grown exponentially in recent years. It will grow from $1.02 billion in 2025 to $1.27 billion in 2026 at a compound annual growth rate (CAGR) of 24.2%. The growth in the historic period can be attributed to increasing demand for accurate tissue analysis, growing adoption of digital pathology, rising need for high-throughput slide examination, expanding use of AI-assisted diagnostics, increasing focus on reducing human error in pathology.

The segmentation artificial intelligence (AI) for pathology slides market size is expected to see exponential growth in the next few years. It will grow to $2.98 billion in 2030 at a compound annual growth rate (CAGR) of 23.9%. The growth in the forecast period can be attributed to growing integration of deep learning in pathology workflows, increasing adoption of automated segmentation tools, rising demand for real-time slide analysis, expanding investment in AI-powered diagnostic platforms, growing emphasis on precision medicine and personalized treatment. Major trends in the forecast period include technology advancements in neural network-based segmentation, innovations in AI-driven pattern recognition, developments in high-resolution digital slide processing, research and development in multi-modal pathology analysis, advancements in cloud-based AI pathology solutions.

The growing prevalence of cancer is expected to drive the growth of the segmentation artificial intelligence (AI) for pathology slides market in the coming years. Cancer is characterized by the uncontrolled growth and spread of abnormal cells, which can damage surrounding tissues and organs if not treated effectively. Its prevalence is increasing due to lifestyle-related risk factors such as poor diet, smoking, alcohol consumption, and exposure to environmental pollutants, which raise the likelihood of developing various cancers. Segmentation AI for pathology slides supports cancer management by automatically identifying and delineating tumor regions within digital tissue images. It enhances diagnostic accuracy and efficiency, enabling more precise treatment planning and personalized therapeutic strategies. For example, in October 2025, NHS Digital, a UK government organization, reported 354,820 new cancer diagnoses in England in 2023 - an average of 972 diagnoses per day and an increase of 8,605 cases compared to 2022. Prostate cancer was the most commonly diagnosed, with 58,137 new cases, reflecting a 6% rise in registrations from the previous year. Consequently, the rising prevalence of cancer is fueling the expansion of the segmentation AI for pathology slides market.

Major companies in the segmentation AI for pathology slides market are focusing on developing advanced tissue segmentation solutions, such as AI-powered whole slide image analysis platforms, to enhance diagnostic accuracy, reduce manual annotation, and accelerate pathology workflows. AI-powered whole slide image analysis platforms are software systems that automatically detect and delineate tissue regions, cells, and anomalies within digital pathology slides, enabling pathologists to conduct accurate and reproducible assessments efficiently. For example, in June 2024, HistoWiz Inc., a US-based digital pathology services company, launched PathologyMap 2.0, an integrated AI-powered whole slide image analysis platform. It performs automated tissue segmentation, provides one-click quality control of whole slide images, and supports flexible metadata integration across slide repositories. These features facilitate rapid tissue identification, streamline slide review, and ensure consistent segmentation outputs for diagnostic and research applications. By combining high-throughput AI segmentation, built-in quality checks, and workflow integration, PathologyMap 2 represents a major advancement in digital pathology, improving both efficiency and diagnostic confidence.

In August 2025, Tempus AI Inc., a US-based technology company, acquired Paige.AI Inc. for approximately $81.2 million. Through this acquisition, Tempus AI aims to enhance its AI-powered digital pathology capabilities by integrating Paige’s advanced algorithms for tissue and cell segmentation, expanding its clinically annotated pathology dataset, and accelerating the development of AI models for cancer detection and diagnostic workflows. This move strengthens Tempus AI’s position in the global digital pathology market. Paige.AI Inc. is a US-based provider of advanced AI algorithms and models for digital pathology that operate on digitized whole-slide images (WSIs).

Major companies operating in the segmentation artificial intelligence (AI) for pathology slides market are PathAI Inc., Lunit Inc., Deciphex Ltd., AetherAI Co. Ltd., Proscia Inc., Aignostics GmbH, Visiopharm A/S, Indica Labs Inc., PathPresenter Ltd., Gestalt Diagnostics Inc., Ibex Medical Analytics Ltd., HistoWiz Inc., Deep Bio Inc., Mindpeak GmbH, Nucleai Ltd., Vuno Inc., Aiosyn B.V., Aiforia Technologies Oyj, Stratipath Medical Ltd., AIVIS Inc.

North America was the largest region in the segmentation artificial intelligence (AI) for pathology slides market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the segmentation artificial intelligence (AI) for pathology slides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the segmentation artificial intelligence (AI) for pathology slides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the segmentation ai for pathology slides market by increasing costs of imported gpus, high-performance computing systems, data storage servers, and advanced imaging hardware used for ai model training and deployment. hospitals and diagnostic laboratories in north america and europe are most affected due to reliance on imported compute infrastructure, while asia-pacific faces higher costs for ai hardware procurement. these tariffs are raising deployment costs and slowing smaller lab adoption. however, they are also encouraging local data center investments, regional ai hardware sourcing, and increased optimization of cloud-based pathology ai platforms.

Segmentation AI for pathology slides refers to artificial intelligence models developed to automatically detect, delineate, and classify specific structures, cells, or regions within digitized pathology slides. These systems assist pathologists by highlighting tumors, tissues, biomarkers, and anomalies with high precision and consistency, improving diagnostic accuracy, reducing analysis time, and supporting advanced research and computational pathology workflows.

The primary components of segmentation artificial intelligence solutions for pathology slides are software, hardware, and services. Software consists of artificial intelligence algorithms that perform automated tissue segmentation and pattern recognition on digitized pathology slides to support diagnostic accuracy and workflow efficiency. These solutions are based on deep-learning segmentation, convolutional neural network models, multi-class tissue classification, and hybrid AI models, deployed through cloud-based platforms, on-premise systems, and hybrid deployments, used in applications such as cancer diagnosis, disease detection, research, drug development, and others, among end users including hospitals, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others.

The segmentation AI for pathology slides market consists of revenues earned by entities by providing services such as image preprocessing, automated annotation, quantitative pathology analysis, workflow automation, and diagnostic decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The Segmentation AI for Pathology Slides market includes sales of cell segmentation, nuclei segmentation, tissue region segmentation, tumor boundary segmentation, and artifact detection segmentation. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.